As part of the state-funded $105 million collaboration between the University at Buffalo and the New York Genome Center (NYGC), the year-old Buffalo Institute for Genomics and Data Analytics (BIG) is helping to develop upstate New York as a national center for genomic medicine research.
University at Buffalo biochemist and genomics entrepreneur Norma Jean Nowak, PhD, professor of biochemistry, has been promoted to executive director of UB’s New York State Center of Excellence in Bioinformatics and Life Sciences (CBLS).
At the 2015 Medical Student Research Forum, aspiring physician-scientists showcased 45 original research projects they conducted at the University at Buffalo, its partner health care agencies and institutions nationwide.
Family Medicine faculty are playing key roles in a $5.8 million clinical trial to improve care and outcomes for patients with coexisting diabetes, hypertension and chronic kidney disease.
A University at Buffalo pilot study using high-resolution magnetic resonance imaging (MRI) links dietary habits with iron levels in the brain — a factor associated with various neurological conditions as well as aging.
An international team led by Jonathan F. Lovell, PhD, assistant professor of biomedical engineering, has created a nanoparticle that may pave the way for “hypermodal” imaging — the ability to merge results from six different imaging modes using one contrast agent.
University at Buffalo researchers have designed a biomedical device that could make chemotherapy more efficient, reduce its side effects and improve how doctors treat some of the most deadly forms of cancer.
With the goal of improving chemotherapy, Jennifer A. Surtees, PhD, associate professor of biochemistry, will study what makes cancer cells sensitive or resistant to different DNA-damaging drugs.
A University at Buffalo biochemist led the first study to identify the liver kinase B1 (LKB1) pathway as a possible therapeutic target for neuropathies, including diabetic neuropathy.
Alan J. Lesse, MD, and John A. Sellick Jr., DO, associate professors of medicine in the Division of Infectious Diseases, presented the latest information about the Ebola virus outbreak at a Mini Medical School lecture, a free public talk.
Anne B. Curtis, MD, Charles and Mary Bauer Professor and chair of medicine, says patients with coronary heart disease and heart failure should not overexert themselves while engaging in cold-weather tasks, such as clearing snow.
“We have no reason to fear Ebola here in the United States, but the situation in West Africa is a grave humanitarian crisis,” Myron L. Glick, MD, told a standing room-only crowd of University at Buffalo medical students and residents shortly after returning from Sierra Leone.
Nearly one-third of adults in and around Fontaine, Haiti, suffer from hypertension, according to a pilot research project led by second-year University at Buffalo medical student Vincenzo Polsinelli.
University at Buffalo Tar Wars volunteers, including medical students, are visiting fourth- and fifth-grade classrooms in Western New York, armed with important lessons about the dangers of smoking.
Males with irritable bowel syndrome (IBS) experience more interpersonal difficulties than do females with the condition, according to research by Jeffrey M. Lackner, PsyD, professor of medicine in the Division of Gastroenterology, Hepatology and Nutrition.
Researchers in the University at Buffalo’s Department of Medicine have been awarded a patent for a test that allows physicians to diagnose the autoimmune disease Sjogren’s syndrome earlier than ever before.
The nonprofit Lighthouse Free Medical Clinic — where University at Buffalo medical students care for uninsured patients — hosted an art opening to promote their services and provide health care information.
Federal approval of new drugs to treat the hepatitis C virus (HCV) represents “a dramatic, positive development for patients,” says University at Buffalo liver disease expert Andrew H. Talal, MD.
A drug developed by University at Buffalo scientists from a small protein found in spider venom is moving forward as a promising treatment for Duchenne muscular dystrophy, a fatal genetic disease affecting boys.
University at Buffalo researchers have helped discover a sleep-promoting circuit in the brainstem, revealing how we fall into deep sleep — findings that may lead to new therapies for sleep disorders.
